BTBD2: A BTB/POZ Domain-Containing Protein (G55643)

Target Name: BTBD2

NCBI ID: G55643

BTBD2

Other Name(s): BTB/POZ domain-containing protein 2 | BTBD2_HUMAN | BTB (POZ) domain containing 2 | BTB (POZ) Domain containing 2 | BTB domain containing 2

BTBD2: A BTB/POZ Domain-Containing Protein

BTBD2 (BTB/POZ domain-containing protein 2) is a protein that is expressed in a variety of tissues and cells in the human body. It is a member of the BTB/POZ family of proteins, which are known for their role in intracellular signaling. BTBD2 is also known as CD28, and it is expressed in many different tissues, including the brain, muscle, heart, and testes.

The BTB/POZ family of proteins is characterized by the presence of a BTB domain and a POZ domain. The BTB domain is a short, acidic region that is found in the N-terminus of the protein, and it is thought to play a role in the formation of intracellular signaling pathways. The POZ domain is a long, acidic region that is found in the C-terminus of the protein, and it is also thought to be involved in intracellular signaling.

BTBD2 is a protein that is expressed in many different tissues and cells in the human body. It is highly expressed in the brain, and it is also found in the muscle, heart, and testes. In the brain, BTBD2 is highly expressed in the cortical regions of the brain, and it is also found in the cerebellum, brainstem, and spinal cord. In the muscle, BTBD2 is highly expressed in the skeletal muscles, and it is also found in the heart and testes.

BTBD2 is involved in a variety of different biological processes in the human body. It is thought to play a role in the regulation of immune responses, and it is also involved in the regulation of cell growth and differentiation. In addition, BTBD2 is thought to be involved in the regulation of cell survival, and it is also involved in the regulation of cell signaling pathways.

BTBD2 is also a potential drug target and a biomarker. BTBD2 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. In addition, BTBD2 has been shown to be involved in the regulation of a variety of signaling pathways, including the T cell signaling pathway and the immune response.

BTBD2 is also a potential biomarker for a variety of diseases. For example, it has been shown to be involved in the regulation of cancer cell proliferation, and it is also involved in the regulation of neurodegenerative diseases. In addition, BTBD2 has been shown to be involved in the regulation of the immune response, and it is thought to play a role in the development of autoimmune diseases.

In conclusion, BTBD2 is a protein that is expressed in many different tissues and cells in the human body. It is a member of the BTB/POZ family of proteins, and it is thought to play a role in a variety of different biological processes in the human body. BTBD2 is also a potential drug target and biomarker, and it is

Protein Name: BTB Domain Containing 2

The "BTBD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BTBD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets